Back to Results
First PageMeta Content
Antivirals / Microbiology / Cytokines / Hepatitis / Hepatitis C virus / Viral hepatitis / Boceprevir / Hepatitis C / Telaprevir / Protease inhibitors / Medicine / Biology


2015 HEPATITIS C MEDICINES Technology and Market Landscape FEBRUARY 2015
Add to Reading List

Document Date: 2015-02-12 12:01:39

Open Document

File Size: 1,88 MB

Share Result on Facebook

City

Geneva / /

Company

BOC / Bristol-Myers Squibb / /

Continent

America / Europe / /

Country

Switzerland / Egypt / United States / China / India / /

Currency

USD / /

/

IndustryTerm

treatment of hepatitis C / pharmaceutical ingredient / together accounting / HCV treatment / diagnostic tools / generic manufacturers / HCV therapeutics / treatment for HCV / generic products / /

MedicalCondition

summary Hepatitis C / HIV / HCV epidemic / malaria / largest HCV epidemic / cirrhosis / Hepatitis C / hepatitis B / HCV / HCV infection / AIDS / HCV-related liver disease / infection / viral hepatitis / HCV infections / combination TPV Telaprevir HCV Hepatitis C / tuberculosis / /

MedicalTreatment

Antiretroviral therapy / /

Organization

Secretariat of UNITAID / World Health Organization / UNITAID’s mission / FDA / Government of Egypt / /

Person

Mike Isbell / Karin Timmermans / Renée Ridzon (Ahimsa) / /

/

Position

advocate / President / Executive / /

Product

ribavirin / DAAs / /

PublishedMedium

Foreword / /

Technology

API / Medicines Technology / genotype / /

URL

www.unitaid.org / /

SocialTag